Literature DB >> 18473818

Programmed cell death mechanisms in neurological disease.

Dale E Bredesen1.   

Abstract

Programmed cell death (pcd) is a form of cell death in which the cell plays an active role in its own demise. Pcd plays a critical role in the development of the nervous system, as well as in its response to insult. Both anti-pcd and pro-pcd modulators play prominent roles in development and disease, including neurodegeneration, cancer, and ischemic vascular disease, among others. Over 100,000 published studies on one form of programmed cell death-apoptosis-have appeared, but recent studies from multiple laboratories suggest the existence of non-apoptotic forms of programmed cell death, such as autophagic programmed cell death. In addition, there appear to be programmatic cell deaths that do not fit the criteria for either apoptosis or autophagic cell death, arguing that additional programs may also be available to cells. Constructing a mechanistic taxonomy of all forms of pcd-based on inhibitors, activators, and identified biochemical pathways involved in each form of pcd-should offer new insight into cell deaths associated with various disease states, and ultimately offer new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473818     DOI: 10.2174/156652408784221315

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  29 in total

1.  Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis.

Authors:  Nichole A Reyes; Jill K Fisher; Kathryn Austgen; Scott VandenBerg; Eric J Huang; Scott A Oakes
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

Review 2.  Human caspases: activation, specificity, and regulation.

Authors:  Cristina Pop; Guy S Salvesen
Journal:  J Biol Chem       Date:  2009-05-26       Impact factor: 5.157

3.  Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes.

Authors:  Takumi Satoh; Tayebeh Rezaie; Masaaki Seki; Carmen R Sunico; Takahito Tabuchi; Tomomi Kitagawa; Mika Yanagitai; Mutsumi Senzaki; Chihiro Kosegawa; Hideharu Taira; Scott R McKercher; Jennifer K Hoffman; Gregory P Roth; Stuart A Lipton
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

4.  Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway.

Authors:  Teresa Jover-Mengual; Takahiro Miyawaki; Adrianna Latuszek; Enrique Alborch; R Suzanne Zukin; Anne M Etgen
Journal:  Brain Res       Date:  2010-01-28       Impact factor: 3.252

Review 5.  Molecular pathogenesis of a novel mutation, G108D, in short-chain acyl-CoA dehydrogenase identified in subjects with short-chain acyl-CoA dehydrogenase deficiency.

Authors:  Kenichiro Shirao; Satoshi Okada; Go Tajima; Miyuki Tsumura; Keiichi Hara; Shin'ichiro Yasunaga; Motoaki Ohtsubo; Ikue Hata; Nobuo Sakura; Yosuke Shigematsu; Yoshihiro Takihara; Masao Kobayashi
Journal:  Hum Genet       Date:  2010-04-08       Impact factor: 4.132

6.  Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection.

Authors:  Muge Yemisci; Secil Caban; Yasemin Gursoy-Ozdemir; Sevda Lule; Ramon Novoa-Carballal; Ricardo Riguera; Eduardo Fernandez-Megia; Karine Andrieux; Partick Couvreur; Yilmaz Capan; Turgay Dalkara
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

7.  A screen of apoptosis and senescence regulatory genes for life span effects when over-expressed in Drosophila.

Authors:  Jie Shen; Christina Curtis; Simon Tavaré; John Tower
Journal:  Aging (Albany NY)       Date:  2009-01-30       Impact factor: 5.682

Review 8.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

Review 9.  Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding.

Authors:  Wendy Noble; Claire J Garwood; Diane P Hanger
Journal:  Prion       Date:  2009-04-21       Impact factor: 3.931

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.